XML 27 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
May 04, 2014
May 05, 2013
Cash flows from operating activities:    
Net earnings $ 46,162 $ 39,466
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:    
Depreciation and amortization 38,630 36,609
Loss on sale/disposal/impairment of assets 644 360
Amortization of deferred lease incentives (5,782) (6,353)
Deferred income taxes (4,649) (3,431)
Tax benefit from exercise of stock-based awards 43,223 9,186
Excess tax benefit from exercise of stock-based awards (21,371) (4,047)
Stock-based compensation expense 12,368 8,991
Other 173 0
Changes in:    
Accounts receivable 5,692 1,512
Merchandise inventories (36,108) (21,537)
Prepaid catalog expenses (1,430) 824
Prepaid expenses and other assets (41,951) (25,863)
Accounts payable (19,276) (52,345)
Accrued salaries, benefits and other current and long-term liabilities (48,164) (37,028)
Customer deposits 5,216 14,691
Deferred rent and lease incentives 3,092 7,613
Income taxes payable (46,798) (28,470)
Net cash used in operating activities (70,329) (59,822)
Cash flows from investing activities:    
Purchases of property and equipment (38,119) (47,444)
Proceeds from insurance reimbursement 33 760
Other 100 26
Net cash used in investing activities (37,986) (46,658)
Cash flows from financing activities:    
Repurchase of common stock (53,309) (41,174)
Payment of dividends (32,891) (21,985)
Tax withholdings related to stock-based awards (46,730) (9,384)
Excess tax benefit from exercise of stock-based awards 21,371 4,047
Net proceeds from exercise of stock-based awards 2,997 3,767
Repayments of long-term obligations 0 (28)
Other (6) 0
Net cash used in financing activities (108,568) (64,757)
Effect of exchange rates on cash and cash equivalents (368) (782)
Net decrease in cash and cash equivalents (217,251) (172,019)
Cash and cash equivalents at beginning of period 330,121 424,555
Cash and cash equivalents at end of period $ 112,870 $ 252,536